Initial results of ongoing phase I/II studies of weekly doxorubicin (Doxo)/docetaxel (Doce) in men with hormone refractory (HRPC) and hormone sensitive prostate cancer (HSPC)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: H. D. Mannuel, N. Dawson, I. Khan, M. Feldman, L. Boyle, M. Besche, J. Smoot, C. Engstrom, M. Monroe, A. Hussain
Institution: University of Maryland, Baltimore
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2281973142